The test MRSA and MSSA directly from blood culture samples in about one hour, compared to between 48 and 72 hours with other methods, the company said.
The activity follows a recent financing round that has enabled OncoDNA to build out its sales team as it courts new clients.
In PLOS this week: chromosomal insertion mechanisms, phylogeographic analysis of the Crimean Congo hemorrhagic fever virus, and more.
The researchers will use single-cell genomics and other approaches to generate information that could ultimately be used to diagnose, monitor, and treat disease.
Researchers found that mutations in this gene increased the risk of chronic obstructive pulmonary disease, bone marrow failure, and other conditions.
The companion test will let doctors identify the best treatment for CLL patients with 17p deletions, a subset that has historically lacked therapeutic options.
The partners will jointly market ASI's imaging platforms with Agilent FISH products to help customers create automated workflows.
The new system emphasizes the importance of tumor biology as an important prognostic indicator for women who undergo neoadjuvant therapy, the researchers said.
Using genomic data for pediatric low-grade gliomas, researchers uncovered a MYB-QKI fusion that appears to drive angiocentric glioma development.
The firm's cytogenetic media, immunohistochemistry products, and fish probes have been certified for marketing in Europe.
The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.
The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.
Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.
In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.